The commitment of IBSA Farmaceutici, the value and the importance of its activities for the patients, and the Company’s contribution to the Country: these are the main topics taken up and analyzed by the national and industry press following the meeting Innovazione, investimenti e ricerca: le sfide di IBSA in Italia (“Innovation, investments and research: IBSA’s challenges in Italy”), which was held last June 15. A media echo that has given visibility to IBSA’s efforts – in the different areas of research, development, production and sustainability – despite the troubles of a difficult period, such as that of the most acute phase of the pandemic, but thanks to which the Company has acquired the awareness of being able to continue to grow and stand out as an important reference for patients, as well as a successful example of the quality of the Made in Italy research and production worldwide.
IBSA’s contribution to the Country’s health system has been an important – and much appreciated – sign, whose importance has been highlighted by some media, also with a view to restarting the economy and continuing to grow the Italian pharmaceutical sector. Here is a small selection of articles have dedicated an in-depth analysis to IBSA’s activities, touching on several highly topical insights and issues.
